In a peer-reviewed study on the real-world effectiveness of updated bivalent mRNA vaccines, researchers at the University of North Carolina’s Gillings School of Global Public Health found that bivalent boosters are more effective than original monovalent boosters at preventing COVID-19 hospitalization and death. The study was published today in The New England Journal of Medicine.
This article was originally published on MedicalXpress.com